Ontology highlight
ABSTRACT: Background
Long-term treatment with glucocorticoids (GCs) plays an important role in the management of arthritis patients, although the efficacy/safety balance is unfavorable. Alternatives with less (severe) adverse effects but with good efficacy are needed. Selective GC receptor modulators (SGRMs) are designed to engage the GC receptor with dissociative characteristics: transactivation of genes, which is mainly responsible for unwanted effects, is less strong while trans-repression of genes, reducing inflammation, is maintained. It is expected that SGRMs thus have a better efficacy/safety balance than GCs. A systematic review providing an overview of the evidence in arthritis is lacking.Objective
To systematically review the current literature on efficacy and safety of ora
SUBMITTER: Safy M
PROVIDER: S-EPMC5739390 | biostudies-literature | 2017
REPOSITORIES: biostudies-literature